Order Article Reprints

Krassnig S, Wohlrab C, Golob-Schwarzl N, Raicht A, Schatz C, Birkl-Toeglhofer AM, Skofler C, Gantenbein N, Leoni M, Asslaber M, et al. A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy. Cancers. 2021; 13(6):1482. https://doi.org/10.3390/cancers13061482

Krassnig, Stefanie, Christina Wohlrab, Nicole Golob-Schwarzl, Andrea Raicht, Christoph Schatz, Anna Maria Birkl-Toeglhofer, Christina Skofler, Nadine Gantenbein, Marlene Leoni, Martin Asslaber, and et al. 2021. "A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy" Cancers 13, no. 6: 1482. https://doi.org/10.3390/cancers13061482

Krassnig, S., Wohlrab, C., Golob-Schwarzl, N., Raicht, A., Schatz, C., Birkl-Toeglhofer, A. M., Skofler, C., Gantenbein, N., Leoni, M., Asslaber, M., Leber, S. L., Mahdy-Ali, K., von Campe, G., Mayer, M., Borenich, A., Weis, S., Benesch, M., & Haybaeck, J. (2021). A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy. Cancers, 13(6), 1482. https://doi.org/10.3390/cancers13061482